C.M. Bidwell & Associates’s Amgen AMGN Stock Holding History

C.M. Bidwell & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.17K	Hold	6	–	–	﹤0.01%	407
2026 Q1	$2.11K	Hold	6	–	–	﹤0.01%	406
2025 Q4	$1.96K	Sell	6 -43	-88%	-$13.6K	﹤0.01%	398
2025 Q3	$13.8K	Sell	49 -413	-89%	-$120K	0.01%	272
2025 Q2	$129K	Buy	+462	New	+$131K	0.07%	156
2024 Q4	–	Sell	-14	Closed	-$4.51K	–	488
2024 Q3	$4.51K	Buy	+14	New	+$4.58K	﹤0.01%	341
2023 Q2	–	Sell	-344	Closed	-$83.2K	–	511
2023 Q1	$83.2K	Hold	344	–	–	0.06%	252
2022 Q4	$90.3K	Hold	344	–	–	0.07%	235
2022 Q3	$78K	Hold	344	–	–	0.06%	244
2022 Q2	$84K	Sell	344 -1	-0.3%	-$245	0.07%	234
2022 Q1	$83K	Hold	345	–	–	0.05%	258
2021 Q4	$78K	Buy	+345	New	+$72.8K	0.05%	258
2019 Q4	–	Sell	-840	Closed	-$163K	–	403
2019 Q3	$163K	Buy	+840	New	+$161K	0.16%	144
2016 Q2	–	Sell	-1,780	Closed	-$267K	–	241
2016 Q1	$267K	Sell	1,780 -21,015	-92%	-$3.12M	0.07%	143
2015 Q4	$3.7M	Buy	+22,795	New	+$3.58M	0.88%	55
2015 Q3	–	Sell	-2,020	Closed	-$310K	–	226
2015 Q2	$310K	Buy	+2,020	New	+$324K	0.07%	132
2014 Q1	–	Sell	-455	Closed	-$52K	–	214
2013 Q4	$52K	Sell	455 -80	-15%	-$9.1K	0.01%	211
2013 Q3	$60K	Hold	535	–	–	0.02%	208
2013 Q2	$52.8K	Buy	+535	New	+$55.5K	0.02%	217

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

C.M. Bidwell & Associates's AMGN Position: Q2 2026 in Review

C.M. Bidwell & Associates held its Amgen (AMGN) position steady in Q2 2026 at 6 shares worth $2.17K. The position accounts for ﹤0.01% of the portfolio, ranked #407.

C.M. Bidwell & Associates first reported a position in AMGN in Q2 2013 and has held it in 19 quarters since. The position peaked at $3.7M in Q4 2015. 3,151 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

C.M. Bidwell & Associates held 6 shares of Amgen worth $2.17K as of Q2 2026.
C.M. Bidwell & Associates left its Amgen share count unchanged in Q2 2026.
Amgen made up ﹤0.01% of C.M. Bidwell & Associates's portfolio in Q2 2026, its #407 holding.
C.M. Bidwell & Associates first reported a position in Amgen in Q2 2013 and has held it in 19 quarters since.
C.M. Bidwell & Associates's Amgen position peaked at $3.7M in Q4 2015.
3,151 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.